A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19
Clinical trial NCT04796402 · UNKNOWN
Trial details
- NCT number
- NCT04796402
- Sponsor
- Fraser Health
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2021-06-07
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.